| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72107 | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Allophycocyanin | FAB4628A | |||
| Biotin | BAF4628 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB4628A | |||
| Carrier Free | AF4628-SP | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | FAB46281U-100UG | |||
| Alexa Fluor 405 | FAB46281V-100UG | |||
| Alexa Fluor 488 | FAB46281G-100UG | |||
| Alexa Fluor 594 | FAB46281T-100UG | |||
| Alexa Fluor 647 | FAB46281R-100UG | |||
| Alexa Fluor 700 | FAB46281N-100UG | |||
| Alexa Fluor 750 | FAB46281S-100UG | |||
| Phycoerythrin | FAB46281P | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | FAB1906U-100UG | |||
| Alexa Fluor 405 | FAB1906V-100UG | |||
| Alexa Fluor 488 | FAB1906G-025 | |||
| Alexa Fluor 594 | FAB1906T-100UG | |||
| Alexa Fluor 647 | FAB1906R-100UG | |||
| Alexa Fluor 700 | FAB1906N-025 | |||
| Alexa Fluor 750 | FAB1906S-100UG | |||
| Allophycocyanin | FAB1906A | |||
| Phycoerythrin | FAB1906P | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1906-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4628-SP | |||
![Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(OTI1F1)-Western-Blot-NBP2-45868-img0005.jpg "Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.")
![Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Paraffin-embedded Carcinoma of Human prostate tissue using anti-SLAMF7 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(OTI1F1)-Immunohistochemistry-Paraffin-NBP2-45868-img0006.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(OTI1F1)-Immunohistochemistry-NBP2-45868-img0001.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(OTI1F1)-Immunohistochemistry-NBP2-45868-img0002.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(OTI1F1)-Immunohistochemistry-NBP2-45868-img0003.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(OTI1F1)-Immunohistochemistry-NBP2-45868-img0004.jpg)
![Western Blot: CRACC/SLAMF7 Antibody [NBP2-37951] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG. Lane 4: Human Plasma](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-Western-Blot-NBP2-37951-img0002.jpg "Western Blot: CRACC/SLAMF7 Antibody [NBP2-37951] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG. Lane 4: Human Plasma")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody [NBP2-37951] - Staining in human tonsil and skeletal muscle tissues using anti-SLAMF7 antibody. Corresponding SLAMF7 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-Immunohistochemistry-Paraffin-NBP2-37951-img0005.jpg)
![Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody [NBP2-37951] - Staining of human skeletal muscle shows low expression as expected.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-Immunohistochemistry-Paraffin-NBP2-37951-img0003.jpg)
![Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody [NBP2-37951] - Staining of human tonsil shows high expression.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-Immunohistochemistry-Paraffin-NBP2-37951-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: CRACC/SLAMF7 Antibody (1B9) [H00057823-M01] - Analysis of monoclonal antibody to SLAMF7 on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7-Antibody-(1B9)-Immunocytochemistry-Immunofluorescence-H00057823-M01-img0002.jpg "Immunocytochemistry/Immunofluorescence: CRACC/SLAMF7 Antibody (1B9) [H00057823-M01] - Analysis of monoclonal antibody to SLAMF7 on HeLa cell. Antibody concentration 10 ug/ml.")
![Sandwich ELISA: CRACC/SLAMF7 Antibody (1B9) [H00057823-M01] - Detection limit for recombinant GST tagged SLAMF7 is 1 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize2/CRACC-SLAMF7 Antibody (1B9)-Sandwich ELISA-H00057823-M01-img0003.jpg)
![Western Blot: SLAMF7 Overexpression Lysate (Adult Normal) [NBP2-04383] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for SLAMF7.](http://images.novusbio.com/fullsize/SLAMF7 Overexpression Lysate (Adult Normal)-Western Blot-NBP2-04383-img0001.jpg "Western Blot: SLAMF7 Overexpression Lysate (Adult Normal) [NBP2-04383] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for SLAMF7.")